Skip to content

Use of Aspirin in gum diseases

Evaluation of Platelet-Rich Fibrin with and without Aspirin complex in the management of bilateral mandibular grade-II furcation defects- A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013337
Enrollment
30
Registered
2018-04-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic Generalised Periodontitis With Mandibular Grade-II Furcation Defects

Interventions

Intervention1: open flap debridement with use of PRF and PRF Aspirin Complex: Regenerative capacity of Platelet rich fibrin and Platelet rich fibrin aspirin complex in Mandibular Grade2 furcation defe

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Bilateral mandibular grade II furcation defects according to Glickmanâ??s classification. 2.Systemic diseases known to influence the periodontal condition and not receiving any medication known to affect the status.

Exclusion criteria

Exclusion criteria: 1.Smokers. 2.Pregnant females. 3.Patient who are under antibiotic coverage for past 1 month. 4.Patients who had received periodontal therapy with in 6months before study are excluded. 5.Patients who are known hypersensitivity or allergy to aspirin are excluded. 6.History of alcohol abuse.

Design outcomes

Primary

MeasureTime frame
Comparative assessment of grade 2 furcation defect fill with PRF and PRF aspirin complexTimepoint: Baseline and six month postoperative

Secondary

MeasureTime frame
Regenerative capacity of PRF alone and PRF aspirin ComplexTimepoint: Base line and six month Postoperative

Countries

India

Contacts

Public ContactVijaykumar Chava

Narayana Dental College

chava7@hotmail.com9441978737

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026